Gabelli & CO Investment Advisers, Inc. Clovis Oncology, Inc. Transaction History

Gabelli & CO Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$42.06 - $62.4 $1.69 Million - $2.5 Million	-40,100 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$50.12 - $67.72 $270,648 - $365,688	5,400 Added 15.56%	40,100 $2.12 Million
Q4 2017 Feb 02, 2018	BUY	$57.69 - $84.58 $305,757 - $448,274	5,300 Added 18.03%	34,700 $2.36 Million
Q3 2017 Nov 01, 2017	BUY	$67.17 - $84.81 $1.97 Million - $2.49 Million	29,400	29,400 $2.42 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.